Bio & Healthcare

We produce and supply chemical materials such as API (Active Pharmaceutical Ingredients) and advanced intermediates through our pharmaceutical business, CleanBio antibacterial in our specialty chemical business, and Besfloc (water treatment agents) through our water solution business.

As a global top-tier company, we lead the product market and strive to develop new biopharmaceuticals based on our accumulated experiences and capabilities.

Our mission is to become a global leader in life science innovation from bio to chemicals.

We introduce new drugs through partnerships with leading pharmaceutical companies and develop and supply various prescription drugs in respiratory medicine, dermatology, pediatrics, and orthopedics. We also supply various over-the-counter drugs and health functional food products, including Apniben Q, the first mouthwash-type stomatitis treatment, and Bicogreen S Tablet, a three-component constipation treatment.

Our main products in each field maintain top positions in market share and are recognized for their value.

KOLON PHARMA aims to become a total healthcare company by developing differentiated medicines and entering various healthcare markets.

We use our TG-C platform, a cellular gene technology, to develop new drugs and succeeded in obtaining a US patent for Gene therapy using TGF-β1 in September 2004. Our mission is to provide safe and effective therapies to patients by developing osteoarthritis treatments for improving clinical symptoms (pain relief, functional improvement) through tissue engineering and suppressing the progress of various degenerative diseases.

In addition, we have been operating and managing the W-STORE online mall, which sells health and beauty products, since August 2017.